Novartis Ireland Limited

Total Lobbying Efforts: 49

All Officials
Select methods...

Lobbying Records (Page 1 of 5)

2025-09-19
Politician(s) lobbied: Thomas Byrne (Minister of State), Department of Foreign Affairs
Intent: Life Science Strategy published in advance of EU Presidency
Methods: Meeting
Details & Methods:
MethodDescription
Attending a meeting organised by Hanover with the Minister for EU Affairs
2025-09-19
Politician(s) lobbied: Professor Mary Horgan (Chief Medical Officer), Department of Health
Intent: A new Life Science Strategy to make Ireland more competitive in biopharma
Methods: Event / Reception
Details & Methods:
MethodDescription
IIEA event with a panel of speakers about Developing a National Life Sciences Vision for Ireland
2025-09-19
Politician(s) lobbied: Colm Burke (TD), Dáil Éireann, the Oireachtas; Malcolm Byrne (TD), Dáil Éireann, the Oireachtas; Pádraig O'Sullivan (TD), Dáil Éireann, the Oireachtas; Shane Moynihan (TD), Dáil Éireann, the Oireachtas; Albert Dolan (TD), Dáil Éireann, the Oireachtas
Intent: RDI asking for support to host an event as part of the EU Presidency on Life Science Strategy
Methods: Event / Reception, Meeting, Email
Details & Methods:
MethodDescription
Rare Disease Ireland invite to Leinster House
2025-09-19
Politician(s) lobbied: Maeve von Heynitz (Ambassador), Department of Foreign Affairs
Intent: Joined an IPHA delegation to discuss the need for the Life Science Strategy to be on the agenda of the EU Presidency
Methods: Meeting
Details & Methods:
MethodDescription
EU Presidency
2025-09-19
Politician(s) lobbied: Jim O'Callaghan (Minister), Department of Justice
Intent: Asked the Minister to raise the need for digital records in healthcare with the Minister for Health.
Methods: Event / Reception
Details & Methods:
MethodDescription
IIEA Meeting with Minister for Justice
2025-09-19
Politician(s) lobbied: Simon Harris (Tánaiste and Minister), Department of Foreign Affairs; Jennifer Carroll MacNeill (Minister), Department of Health; Robert Watt (Secretary General), Department of Health; Colm Henry (Chief Clinical Officer), Health Service Executive; Bernard Gloster (Chief Executive Officer), Health Service Executive
Intent: To secure a meeting with Tanaiste and Minister for Health
Methods: Letter, Email
Details & Methods:
MethodDescription
Letter to Tanaiste about access to innovative treatment for Irish patients
2025-09-19
Politician(s) lobbied: Darragh O'Brien (Minister), Department of Climate, Energy and the Environment
Intent: Meeting sought with officials around Ireland's vote on an EU exemption for development of RLT in the EU. The EU Mercury Committee meeting scheduled in Sept.
Methods: Email
Details & Methods:
MethodDescription
EU Mercury Committee
2025-09-19
Politician(s) lobbied: Jennifer Carroll MacNeill (Minister), Department of Health
Intent: Advocate for Life Science Strategy and access to innovation
Methods: Event / Reception
Details & Methods:
MethodDescription
Launch of the Rare Disease National Strategy at Department of Health
2025-09-11
Current/Former DPOWhat is lobbying? (FAQ)
Politician(s) lobbied: Simon Harris (Minister), Department of Foreign Affairs
Intent: Ireland is seen as a country that values innovation and innovative new medicines
Methods: Meeting
Details & Methods:
MethodDescription
IPHA Industry meeting - engagement on trade and tariff issues
2025-09-11
Politician(s) lobbied: Jennifer Carroll MacNeill (Minister), Department of Health; Simon Harris (Tánaiste and Minister), Department of Foreign Affairs; Thomas Byrne (Minister of State), Department of the Taoiseach; James Lawless (Minister), Department of Further and Higher Education, Research, Innovation and Science; Peter Burke (Minister), Department of Enterprise, Trade and Employment; Peter Burke (Minister), Department of Enterprise, Trade and Employment
Intent: Rare diseases conference, as an official event of the Irish EU Presidency. Asking for support to host a rare diseases conference on the theme 'embedding research and innovation as standard in rare disease care' as an official event of the Irish EU Presidency. This would allow Ireland to showcase excellence in Irish research while also highlighting the positive impact this work has on the lives of people living with rare diseases, their families and wider society.
Methods: Email
Details & Methods:
MethodDescription
Rare diseases conference
as an official event of the Irish EU Presidency